The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 2-10A Indolent Lymphoma: Treatment

Sat. Oct 12, 2019 9:00 AM - 10:00 AM No.10 (Tokyo International Forum, 4F G409)

Chair: Ilseung Choi (Dep. Hematology, NHO Kyushu Cancer Center)

[OS2-10A-2] Analysis of predictors for therapeutic efficacy and adverse events in ibritumomab tiuxetan therapy

Ayaka Kume1, Akira Toriihara2, Ryo Shimizu1, Naoki Harada3, Jun Isogai3, Hiroaki Tanaka1 (1.Department of Hematology, Asahi General Hospital, Chiba, Japan, 2.Department of Nuclear Medicine, Asahi General Hospital, Chiba, Japan, 3.Department of Radiology, Asahi General Hospital, Chiba, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password